<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000655254"><TermName>relapse-free survival</TermName><TermPronunciation>(REE-laps … ser-VY-vul)</TermPronunciation><TermDefinition><DefinitionText>In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer. In a clinical trial, measuring the relapse-free survival is one way to see how well a new treatment works. Also called DFS, disease-free survival,  and RFS.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000734675" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;relapse-free survival&quot;" language="en" id="_3"/><MediaLink ref="CDR0000734676" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;supervivencia sin recaída&quot;" language="es" id="_4"/><SpanishTermName>supervivencia sin recaída</SpanishTermName><SpanishTermDefinition><DefinitionText>En el ámbito del cáncer, es el período que transcurre después de terminar un tratamiento para el cáncer durante el que el paciente sobrevive sin signos o síntomas  de la enfermedad. de la supervivencia sin recaída es una manera de comprobar la eficacia de un tratamiento nuevo. También se llama SSE, SSR,  y supervivencia sin enfermedad.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2012-04-11</DateFirstPublished><DateLastModified>2012-08-15</DateLastModified></GlossaryTerm>
